secwatch.observer — SEC 8-K summary
======================================

Issuer:     BECTON DICKINSON & CO (BDX)
CIK:        0000010795
Form:       8-K
Filed at:   2024-06-07T23:59:59+00:00
Accession:  0001140361-24-029309
Event type: debt
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BD issues €1.8B + $600M notes to fund Edwards Critical Care acquisition
-----------------------------------------------------------------------

- €1.0B 3.828% notes due 2032, €800M 4.029% notes due 2036, $600M 5.081% notes due 2029 issued June 7.
- Net proceeds, with commercial paper and cash, to fund cash consideration for Edwards Lifesciences Critical Care buy.
- If acquisition not closed by June 3, 2025, notes subject to special mandatory redemption at 101% of par.
- Proceeds not escrowed; issuances not conditioned on deal completion.
- BD fully guarantees Becton Finance €800M notes; all notes are senior unsecured.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/10795/000114036124029309/0001140361-24-029309-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/10795/000114036124029309/ny20030306x14_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-24-029309

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer